Related Experiment Video
Updated: Jul 15, 2026
09:40
Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Analysis of recombinant protein toxicity in E. coli through a phage lambda-based genetic screening system.
Guerau Fernández1, Andrea Vera, Antonio Villaverde
1Fundació irsiCaixa, Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol, 08916, Badalona, Spain.
Biotechnology Letters
|May 5, 2007
Summary
The human immunodeficiency virus type 1 (HIV-1) protease is toxic to E. coli, but its toxicity is not due to its enzymatic activity. A new screening system effectively analyzes toxic recombinant products in E. coli.
Area of Science:
- Molecular biology
- Virology
- Biochemistry
Background:
- The aspartic protease from human immunodeficiency virus type 1 (HIV-1) causes toxicity in E. coli, hindering production yields.
- Proteolytic cleavage of essential cellular proteins is a suspected cause of this toxicity, but it remains unproven.
Purpose of the Study:
- To investigate the cause of HIV-1 protease toxicity in E. coli.
- To evaluate a novel high-throughput screening system for analyzing toxic recombinant products.
Main Methods:
- Utilized an adapted high-throughput lambda-based screening system to analyze HIV-1 protease mutants with varying catalytic properties.
- Incorporated data from directed molecular evolution approaches.
Main Results:
- Inactive HIV-1 protease mutants exhibited toxicity levels comparable to the wild-type enzyme.
- Demonstrated that the toxicity of HIV-1 protease is independent of its proteolytic activity.
- Established the lambda-based screening system as a robust tool for genetically analyzing highly toxic recombinant products in E. coli.
Conclusions:
- The toxicity of HIV-1 protease in E. coli is not linked to its proteolytic function.
- The developed lambda-based screening system is effective for studying toxic recombinant proteins in microbial hosts.
